Growth overstated, cost pressures real; margins resilient but under watch

Delivered revenue 8.2% YoY (5000 Cr vs prior-year base)

Delivered PAT growth 14.1% (593.4 Cr)

Avg quarter growth 9.5%; June exit claim unverifiable but inconsistent with 9.5% avg

9% volume growth + ~1% pricing = ~10% nominal; close to delivered 8.2% (mix of prior-year base and mix effect)

Claimed shrinkflation + 1% pricing only offset ~50%; other 50% absorbed in COGS

Rural/wholesale channels normalized after Apr-May disruption; June throughput recovery in General Trade confirmed. Reverses FY26 pressure.

LPG/PNG indexed 1.5x of Feb (from 2.5x peak Apr-May) but far above normal; sugar +₹7/kg; palm oil +20%. Commodity tailwind expectations reversed.

Shifted to 'shrinkflation' (lower pack content, same INR 5/10 price) as primary lever, preserving volume. Explicit + 1.5–2% pricing expected going fwd vs Q1's 1%.

Croissant now ₹200 Cr ARR (doubled from prior stated ₹100 Cr), 30%+ growth. Cake/rusk/wafers, dairy all double-digit growth; non-biscuit portfolio grew double-digits overall.

No change to strategy; Middle East/North America headwinds acknowledged. Africa (Kenya) performing well. New intl head to stabilize, but execution unclear.

Dual pricing ended by June; demand held organically. Retailers who switched temporarily returned. Volume growth strong, demand environment continues positive.

LPG volatility at 1.5x index (still elevated). Only 50% of inflation offset via price/shrinkflation; other half absorbed. Ad spends ahead of sales growth but not quantified.

Double the ₹100 Cr (so ~₹200 Cr), growing 30%+. Margins equal/slightly accretive to company average.

New definition of 'key states' = largest/most profitable (not Hindi belt focus states). Both key & other states accelerating. Q-com now 80–85% of e-comm, healthy double-digit growth.

Restructuring complete; new Strategy & Corp Dev head joined this week. Phantom stock charge ~₹1 Cr (vs ₹52 Cr prior yr).

Future platforms (health/wellness, protein) in development; internal teams working on portfolio expansion beyond bakery. Company committed but no timeline given.

Headcount added in challenged markets. Sub-distributors converted to direct where possible. Empowerment via local media, influencers, regional product innovation (e.g., Thirukkural Milk Bikis in TN). SKU structure unchanged; execution changed.

One quarter in; trend good but uncertain. Internally confident plans will drive results. 'Good year' = virtuous triangle of volume, value, profitability all healthy, no one at cost of another.

~9% tonnage growth, which in any respect is good.

No older inventory benefit. Will manage between value, volume, margin. If input costs remain, will deliver but need to see how exit plays out.

No PLI booked FY26 or FY27 Q1; threshold growth target not met. Zero impact to P&L.

Yes, will accelerate exclusive e-comm/quick-commerce product launches soon (vague timeline).

GT is INR 5/10 heavy (~60% portfolio); e-comm/Q-com is larger packs + impulse adjacencies (Croissant, Jim Jam, Little Hearts). Non-biscuit share higher in modern.

Q1 was shrinkflation (low realization). Q2+ expect +1.5–2% pricing (packaging/mix changes take time to execute).

Not destocking; throughput clean. Wholesalers' retail shelves turn fast. Dual-pricing-impacted retailers returned to buy in strong numbers.

Britannia's 60%+ sales in INR 5/10 packs → elasticity muted vs higher-price-point categories. Consumer gets extra cookie, not price drop. Real impact gradual. Larger packs minority of mix.

Protein part of health platform; address at platform level, not single product. Will see in near future but timeline vague.

Total tonnage growth, not adjusted for shrinkflation separately.

Sep only month with challenge (GST transition buying confusion). Jul/Aug normal. Sep will have base impact, applies to peers too.

Dual pricing masked share capture (competition at ₹4.50, Britannia at ₹5). Now sequentially gaining share across biscuit categories post-resolution. Intl business: 4 months turbulence; new head in place; expect growth track from Q2.

Health platform in development; protein important pillar. Core portfolio (indulgent) still has growth runway (per capita consumption low). Both tracks will grow in parallel.

Open to M&A if brand/speed/capability tailwind, but selective. Won't buy another cookie company if can build organically. Will evaluate accretive opportunities.

Strong in all channels vs market. Internally under-indexed in some, focus on effectiveness (visibility, share of handlers) vs numeric points. Modern trade margin-careful—want to grow profitably.

Vague forward guide. Internally confident but acknowledges uncertain external events beyond control. No numeric target provided.

Shrinkflation execution ramp-up post-machinery changes. Management specific on incremental realization vs Q1.

Conditional guidance. Management will manage levers (volume, value, margin) to maintain. But only 50% of input inflation mitigated; rest absorbed.

Q1 OP growth 12.7%, revenue 8.2%—margin expansion achieved. But input headwinds may reverse this; guidance vague.

LPG/PNG index 1.5x normal (vs 2.5x Apr-May peak); sugar +₹7/kg in last 2-3 weeks; palm oil +20% at ₹140. Management explicitly stated only 50% mitigation via pricing/shrinkflation; other 50% absorbed in COGS. Festive season sugar risk.

60%+ of Britannia sales in INR 5/10 fixed-price packs. GST benefit taken as content boost (extra cookie) rather than price reduction. Elasticity of volume/unit demand muted. Large-pack discounts (INR 100–200 range) only minority; competitor visibility low in GT shelves.

Middle East (Saudi) challenged; North America market headwinds. 4 months of turbulence acknowledged. New head of international business joined 2 months prior; execution risk on stabilization. Geopolitical uncertainty (mgmt cannot forecast).

Management claimed 9.5% YoY revenue growth in call; delivered 8.2% actual (per database). Claim of 'mid-teens' June exit inconsistent with 9.5% quarter average—implies Apr-May softness masked by month-end pull. Analysts (Mihir Shah, Arnab Mitra, Latika Chopra) pressed hard on this; no satisfactory explanation.

Management repeatedly cited future health & wellness platform + protein category as strategic pillar but provided no timelines, quantified targets, or mechanism. 'Internal teams working', 'you have to wait and watch' are vague commitments. Regulatory risk in healthy snacking not fully addressed.